Literature DB >> 16105479

The role of statins in the prevention of ischemic stroke.

Bo Ziedén1, Anders G Olsson.   

Abstract

Statin treatment has been demonstrated to diminish the risk for stroke in patients with coronary heart disease, hypercholesterolemia, normocholesterolemia, in the elderly, and among hypertensive and diabetic patients. Stroke incidence in patients on statin treatment has been reduced in all these clinical settings involving both primary and secondary prevention but not in patients with previous stroke. Two recent meta-analyses confirm this conclusion. The mechanism by which statins provide benefit against stroke is likely multifactorial, involving both the low-density lipoprotein cholesterol-lowering effect with stabilization of vulnerable plaques, and pleiotropic effects such as improvement of endothelial function, increased nitric oxide bioavailability, antioxidant properties, inhibition of inflammatory responses, immunomodulatory actions, and regulation of progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105479     DOI: 10.1007/s11883-005-0048-7

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  22 in total

Review 1.  The role of statins in preventing stroke.

Authors:  Nenad Trubelja; Carl Vaughan; Neil L Coplan
Journal:  Prev Cardiol       Date:  2005

2.  American Heart Association Prevention Conference IV: prevention and rehabilitation of stroke: executive summary.

Authors:  C M Helgason; P A Wolf
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

3.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

Review 4.  Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.

Authors:  Pierre Amarenco; Julien Labreuche; Philippa Lavallée; Pierre-Jean Touboul
Journal:  Stroke       Date:  2004-10-28       Impact factor: 7.914

5.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

6.  Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

Authors: 
Journal:  Lancet       Date:  1995 Dec 23-30       Impact factor: 79.321

7.  Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy.

Authors:  David D Waters; Gregory G Schwartz; Anders G Olsson; Andreas Zeiher; Michael F Oliver; Peter Ganz; Michael Ezekowitz; Bernard R Chaitman; Sally J Leslie; Theresa Stern
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

8.  Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

Authors:  M Endres; U Laufs; Z Huang; T Nakamura; P Huang; M A Moskowitz; J K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

10.  Rising statin use and effect on ischemic stroke outcome.

Authors:  Sung Sug Yoon; James Dambrosia; Julio Chalela; Mustapha Ezzeddine; Steven Warach; Joseph Haymore; Lisa Davis; Alison E Baird
Journal:  BMC Med       Date:  2004-03-23       Impact factor: 8.775

View more
  4 in total

Review 1.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

Review 2.  Can we use statins to prevent stroke in Fabry disease?

Authors:  J M Politei
Journal:  J Inherit Metab Dis       Date:  2009-06-02       Impact factor: 4.982

3.  Pretreatment with simvastatin upregulates expression of BK-2R and CD11b in the ischemic penumbra of rats.

Authors:  Jian-Ying Zhang; Qing-Ke Bai; Ying-Dong Zhang
Journal:  J Biomed Res       Date:  2018-09-29

Review 4.  Microglia-mediated neuroinflammation and neuroplasticity after stroke.

Authors:  Yuan Wang; Rehana K Leak; Guodong Cao
Journal:  Front Cell Neurosci       Date:  2022-08-16       Impact factor: 6.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.